Cingulate Inc. (CING)
NASDAQ: CING · Real-Time Price · USD
4.190
+0.200 (5.01%)
At close: Aug 22, 2025, 4:00 PM
4.170
-0.020 (-0.48%)
After-hours: Aug 22, 2025, 4:22 PM EDT
Cingulate Market Cap
Cingulate has a market cap or net worth of $22.68 million as of August 22, 2025. Its market cap has increased by 604.07% in one year.
Market Cap
22.68M
Enterprise Value
19.28M
1-Year Change
604.07%
Ranking
Category
Stock Price
$4.19
Market Cap Chart
Since the IPO on December 8, 2021, Cingulate's market cap has decreased from $64.29M to $22.68M, a decrease of -64.72%. That is a compound annual growth rate of -24.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2025 | 21.60M | 32.67% |
| Dec 31, 2024 | 16.28M | 127.09% |
| Dec 29, 2023 | 7.17M | -36.62% |
| Dec 30, 2022 | 11.31M | -63.77% |
| Dec 31, 2021 | 31.21M | -51.44% |
| Dec 8, 2021 | 64.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 637.23B |
| Johnson & Johnson | 430.92B |
| AbbVie | 370.09B |
| UnitedHealth Group | 274.74B |
| AstraZeneca | 250.88B |
| Novartis AG | 246.51B |
| Novo Nordisk | 246.31B |
| Abbott Laboratories | 229.74B |